Istituto nazionale Per la Ricerca sul Cancro

Genova 16132

0 studies enrolling now · 5 studies all time

What they study most

Adenocarcinoma of the Lung, BRAF or NRAS Mutant Metastatic Melanoma, Mesothelioma, Non-Small Cell Lung Cancer, Squamous Cell Carcinoma, Non-Small-Cell Lung

Studies at this site

• A Multinational, Randomized, Open-Label Study of Custirsen In Patients With Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer — Completed
• A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma — Completed
• A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung — Completed
• Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer — Completed
• Nintedanib (BIBF 1120) in Mesothelioma — Stopped early